An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Lifestyle program, Lifestyle program + coach, Lifestyle program + coach + CGM.
- Who it may be relevant to
- Registry conditions: Diabetes Type 2. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Netherlands
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
"An Online Personalised Lifestyle Program With a Virtual AI Lifestyle Coach in Combination With Continues Glucose Monitoring for People With Type 2 Diabetes."
Overview
The aim of this study is to evaluate the feasibility and effectiveness of a remote personalised lifestyle program in individuals with T2D. Outcomes will be assessed at the start and after 3, 6, and 12 months with two follow-up measurements (18 and 24 months) to determine whether participation in this re-mote lifestyle program leads to improvements in health and diabetes-related outcomes.
Detailed description
Rationale: An estimated 400,000 individuals in the Netherlands are living with undiagnosed type 2 diabetes (T2D), in addition to 1.1 million diagnosed cases. Unhealthy lifestyle behaviours are a major contributing factor. Intensive lifestyle interventions and Continuous Glucose Monitoring (CGM) have demonstrated effectiveness in improving health behaviour and glycaemic control. Digital health technologies, including personalised digital interventions and virtual coaching enable continuous, scalable and context-specific support, thereby facilitating sustained behaviour change and improved self-management. Remote lifestyle interventions are therefore promising and may enhance self-management and glycaemic control, reduce medicine use and delay the development of comorbidities and diabetes-related complications. This study evaluates a remote, personalised lifestyle program combining online group sessions, peer support, CGM use, and a virtual AI lifestyle coach for individuals living with T2D.
Objective: The objective of this study is to evaluate the added value of CGM, biofeedback and a virtual AI lifestyle coach providing personalised, data-driven support within a first prototype of a remote lifestyle intervention for adults with T2D. Specifically, this pilot randomized controlled trial aims to assess the incremental effects of CGM, biofeedback and AI supported personalised coaching, informed by glucose data, demographics, behaviour, goals and preferences on health behaviours and glycaemic control over a 12-month period with two follow-up measurements.
Study design: This three-arm parallel-group randomized controlled trial includes:
1. A lifestyle program consisting of online group sessions and a peer support community. 2. The same lifestyle program supplemented with a virtual AI lifestyle coach. 3. The AI-supported program with four times CGM use.
Study population: Adults (n=160) with T2D (HbA1c ≥53 mmol/mol) without glucose lowering medication (except Metformin), both men and women from all ethnic backgrounds.
Intervention: Participants complete an online baseline questionnaire and a brief in-app intake prior to randomization. All participants attend online group sessions and may engage with peers via the online community. The AI lifestyle coach uses the baseline data to have personalised coaching conversations with the participant throughout the intervention. In the third arm, real-time CGM data are additionally integrated into the AI-driven personalisation process.
Main study parameters/endpoints: The primary outcome is change in HbA1c from baseline to 12 months. Secondary outcomes include changes in physiological (e.g. body weight), clinical (e.g. time in range), behavioural (e.g. dietary intake), and psychological (e.g. quality of life) outcomes.
Interventions
- Behavioral Lifestyle program
Participants are asked to work on improving their lifestyle. They have access to an online community throughout the study, where they can get in touch with other participants within their research-arm. Participants are also asked to attend twelve online group sessions, during which a lifestyle coach will explain more about nutrition, physical activity, sleep, stress, social aspects, challenges and setbacks, and long-term maintenance. - Device Lifestyle program + coach
Idem to arm one, supplemented with a virtual AI lifestyle coach. The AI lifestyle coach can process all the information about the participant that was provided at baseline. This information is compiled into a participant profile, which the AI lifestyle coach uses to initiate personalised conversations with the participant. During these conversations, the AI lifestyle coach supports the participant through a structured coaching cycle of three phases: preparation (reflecting on what matters and co - Device Lifestyle program + coach + CGM
Idem to arm two, but participants are also asked to wear an CGM four times for two consecutive weeks. The glucose values information collected by the CGM is used by the AI lifestyle coach to make conversations with the participant even more personalized. The use of CGMs is an additional topic to the online group sessions.
Primary outcome measures
- Change in HbA1c levels [Time frame: From the beginning of the study to the end of the study at 12 months]
Secondary outcome measures (10)
- Change in body weight [Time frame: From the beginning of the study to the end of the study (12 months), including the two follow-up measurements at 18 and 24 months]
- Change in blood pressure [Time frame: From the beginning of the study to the end of the study (12 months)]
- Change in medication use [Time frame: From the beginning of the study to the end of the study (12 months), including the two follow-up measurements at 18 and 24 months]
- Change in waist and hip circumference [Time frame: From the beginning of the study to the end of the study (12 months), including the two follow-up measurements at 18 and 24 months]
- Change in habitual dietary intake assessed with the Nutri+ instrument [Time frame: From the beginning of the study to the end of the study (12 months), including the two follow-up measurements at 18 and 24 months]
- Change in glycaemic regulation assessed with CGM and blood sample [Time frame: From the beginning of the study to the end of the study (12 months)]
- Change in albumin-creatinine ratio [Time frame: From the beginning of the study to the end of the study (12 months)]
- Study evaluation [Time frame: Once at the end of the study at 12 months]
- Tailoring [Time frame: Once at the end of the study at 12 months]
- Change in quality of life [Time frame: At the start of the study and at the two follow-up measurements at 18 and 24 months]
Eligibility criteria
Inclusion criteria
- Age: ≥18 years
- HbA1c: ≥53 mmol/mol (7 - 12%)
- Signed informed consent form and willing to comply with the study procedures
- Persons who are naïve for participation in a lifestyle program for the past two years
- Being digitally competent
- Mastering the Dutch language
- Accepting the confidential use and storage of anonymised data for analysis and publication (at least 15 years)
Exclusion criteria
- Medication use: any other glucose-lowering medication than metformin
- Comorbidities or medical conditions requiring a special diet that conflicts with the study
- Unstable body weight in the three months prior to inclusion in the study (±5% change based on body weight)
- Circumstances that lead to unreliable HbA1c values, such as blood donation
- Pregnant or lactating women
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Netherlands · 1 center
- University of Twente — Enschede
Identifiers
NCT: NCT07661381 · NL011950 · NL011950